Release Date: 14/08/13 08:50 Summary: Results Investor Presentation Price Sensitive: No Download Document 226.67KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago